06:53 AM EDT, 08/01/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q2 adjusted earnings Friday of $12.89 per diluted share, up from $11.56 a year earlier.

Analysts surveyed by FactSet expected $8.43.

Revenue for the quarter ended June 30 was $3.68 billion, compared with $3.55 billion a year earlier.

Analysts polled by FactSet expected $3.29 billion.